Literature DB >> 9168113

Distinct ATP receptors on pain-sensing and stretch-sensing neurons.

S P Cook1, L Vulchanova, K M Hargreaves, R Elde, E W McCleskey.   

Abstract

The initial pain from tissue damage may result from the release of cytoplasmic components that act upon nociceptors, the sensors for pain. ATP was proposed to fill this role because it elicits pain when applied intradermally and may be the active compound in cytoplasmic fractions that cause pain. Moreover, ATP opens ligand-gated ion channels (P2X receptors) in sensory neurons and only sensory neurons express messenger RNA for the P2X3 receptor. To test whether ATP contributes to nociception, we developed a tissue culture system that allows comparison of nociceptive (tooth-pulp afferent) and non-nociceptive (muscle-stretch receptor) rat sensory neurons. Low concentrations of ATP evoked action potentials and large inward currents in both types of neuron. Nociceptors had currents that were similar to those of heterologously expressed channels containing P2X3 subunits, and had P2X3 immunoreactivity in their sensory endings and cell bodies. Stretch receptors had currents that differed from those of P2X3 channels, and had no P2X3 immunoreactivity. These results support the theory that P2X3 receptors mediate a form of nociception, but also suggest non-nociceptive roles for ATP in sensory neurons.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9168113     DOI: 10.1038/387505a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  131 in total

1.  Expression of the P2X(2) receptor subunit of the ATP-gated ion channel in the cochlea: implications for sound transduction and auditory neurotransmission.

Authors:  G D Housley; R Kanjhan; N P Raybould; D Greenwood; S G Salih; L Järlebark; L D Burton; V C Setz; M B Cannell; C Soeller; D L Christie; S Usami; A Matsubara; H Yoshie; A F Ryan; P R Thorne
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Excitatory effect of P2X receptor activation on mesenteric afferent nerves in the anaesthetised rat.

Authors:  A J Kirkup; C E Booth; I P Chessell; P P Humphrey; D Grundy
Journal:  J Physiol       Date:  1999-10-15       Impact factor: 5.182

3.  In vivo pathway of thermal hyperalgesia by intrathecal administration of alpha,beta-methylene ATP in mouse spinal cord: involvement of the glutamate-NMDA receptor system.

Authors:  M Tsuda; S Ueno; K Inoue
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

4.  Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue.

Authors:  M F Jarvis; C T Wismer; E Schweitzer; H Yu; K J Lynch; E C Burgard; E A Kowaluk
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

5.  Allosteric control of gating and kinetics at P2X(4) receptor channels.

Authors:  B S Khakh; W R Proctor; T V Dunwiddie; C Labarca; H A Lester
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

Review 6.  Nociceptors for the 21st century.

Authors:  F J Alvarez; R E Fyffe
Journal:  Curr Rev Pain       Date:  2000

7.  Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors.

Authors:  Valeria Spelta; Lin-Hua Jiang; Annmarie Surprenant; R Alan North
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

8.  The Meissner corpuscle revised: a multiafferented mechanoreceptor with nociceptor immunochemical properties.

Authors:  M Paré; R Elde; J E Mazurkiewicz; A M Smith; F L Rice
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

9.  Ca2+/calmodulin-dependent protein kinase II potentiates ATP responses by promoting trafficking of P2X receptors.

Authors:  Guang-Yin Xu; Li-Yen Mae Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-03       Impact factor: 11.205

Review 10.  Crossing the pain barrier: P2 receptors as targets for novel analgesics.

Authors:  C Kennedy; T S Assis; A J Currie; E G Rowan
Journal:  J Physiol       Date:  2003-09-26       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.